- Home
- THCH vs BTMD Comparison
THCH vs BTMD Comparison
Compare THCH & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THCH | BTMD |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.7M | 80.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | THCH | BTMD |
|---|---|---|
| Price | $2.27 | $2.34 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 15.1K | ★ 171.0K |
| Earning Date | 12-09-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | $188,274,078.00 | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | ★ N/A | $2.98 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $1.95 | $2.32 |
| 52 Week High | $3.80 | $6.03 |
Technical Indicators
Market Signals| Indicator | THCH | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 47.97 | 36.85 |
| Support Level | $2.08 | $2.38 |
| Resistance Level | $2.66 | $2.68 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 41.38 | 1.19 |
Price Performance
Historical ComparisonAbout THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.